Showing 821-830 of 3230 results for "".
Modifying Masseters and More
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/modifying-masseters-and-more/19698/Artful use of neurotoxin in the masseters and parotid glands can help thin the appearance of the face. Chytra Anand, MD discusses her approach and talks about treatments used in her home country of India.Considering Aesthetic Combinations
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/considering-aesthetic-combinations/19684/Whether it's the use of two or more devices or the addition of fillers or neurotoxins to device-based treatments, combination approaches can improve outcomes and potentially reduce downtime, Nazanin Saedi, MD explains.Antiaging Medicine Meets Aesthetics
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/antiaging-medicine-meets-aesthetics/18883/Antiaging medicine supports overall patient health and can be a complement to aesthetic medicine. Greg Buford, MD talks about anti aging medicine and its role in his practice.Positive Changes in My Practice
https://practicaldermatology.com/topics/practice-management/positive-changes-in-my-practice/19044/Sometimes relatively simple changes can have a big impact on a practice. Steve Yoelin, MD talks about positive changes he has made in his practice.Management of the Periocular Area
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/management-of-the-periocular-area/19210/Richard Anderson, MD reviews his presentation on the proper approach to cosmetic management of the periocular area and mid-face at Vegas Cosmetic Surgery 2013. He discusses blepharoplasty, toxins, fillers, and more. VCS2013SAFE Step Act Update
https://practicaldermatology.com/series/skin-minute/safe-step-act-update/54846/Colby Evans, MD, former chair of the National Psoriasis Foundation Board of Directors, discusses the progress of the SAFE Step Act, which he said continues to garner bipartisan support and could advance in Congress this year.Strategies for Treating Patients on GLP-1 Receptor Agonists and More
https://practicaldermatology.com/conferences/maui-derm-hawaii-2026/strategies-for-treating-patients-on-glp-1-receptor-agonists-and-more/54646/Suneel Chilukuri, MD, discusses key takeaways from the “What’s My Treatment? How to Combine Dermal Filler, Neuromodulators, Laser/Light/RF Devices/Microneedling and Cosmeceuticals Symposium” workshop at Maui Derm Hawaii 2026.Evaluating Roflumilast for Seborrheic Dermatitis
https://practicaldermatology.com/series/skin-minute/evaluating-roflumilast-for-seborrheic-dermatitis/54610/Practical Dermatology Editorial Board member Raj Chovatiya, MD, PhD, MSCI, discusses results from the Phase 3 STRATUM trial studying the efficacy of roflumilast for the treatment of seborrheic dermatitis in patients with diverse skin types.Pressing Unmet Needs in Atopic Dermatitis Management
https://practicaldermatology.com/programs/dermatology-hub-neuroimmune-network/derm-hub/37177/Justin Marson, MD, Chief Resident 2024-25 in the Department of Dermatology at SUNY Downstate Health Science University, discusses some of the most important needs in atopic dermatitis diagnostics and treatment.Growing into the Role of a KOL
https://reachmd.com/programs/practical-dermatology/tbd/39738/Michael H. Gold, MD, founder/medical director of Gold Skin Care Center, shares his path and strategies becoming a key opinion leader in dermatology. This video was recorded at the Science of Skin Summit in Austin, TX.